Auckland Radiation Oncology

What Auckland Radiation Oncology does

Auckland Radiation Oncology (ARO) is a privately held radiation oncology centre and joint venture between Allevia Hospitals (formerly MercyAscot) and Southern Cross Healthcare, established in 2008 as New Zealand's first private radiation therapy treatment facility. It delivers outpatient radiation therapy services to cancer patients referred by GPs, surgeons, and medical oncologists across New Zealand, treating 70-100 patients daily at its Epsom flagship site with virtual consultations extending its reach to Whangarei, Hamilton, Hawkes Bay, Palmerston North, Wellington, and Dunedin.

The clinical offering centres on the only CyberKnife robotic radiotherapy system in New Zealand (sub-millimetre / 50 micrometre real-time tumour tracking), a complementary Elekta Evo linear accelerator with AI-enhanced Iris imaging, an Elekta Linac, and the first Canon Aquilion Exceed Large Bore CT scanner installed in Australasia. Treatment modalities span VMAT, IGRT, IMRT, 3DCRT, electron therapy, and SBRT/SABR across prostate, brain, spine, liver, pancreatic, breast, lung, bowel, gynaecological, head and neck, and skin cancers. ARO's care model bundles dietetic, physiotherapy, psychological, palliative, and accommodation support services.

Revenue is generated through private, pay-per-course treatment fees, funded by a mix of patient self-pay and health insurance reimbursement. Treatment pricing is not publicly disclosed; CyberKnife courses are characterised as 'private' and not cheap. Distribution is driven by medical professional referral channels, GP CME engagement, patient testimonials, and content marketing, with a small number of healthcare-magazine partnerships. A second facility on Auckland's North Shore (Rosedale) opened in October 2025, adding the only private radiation oncology centre north of the Harbour Bridge and approximately 1,000+ annual patient capacity.

Name

Auckland Radiation Oncology

Legal name

Auckland Radiation Oncology

Website

https://aucklandradiationoncology.co.nz

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Auckland Radiation Oncology is a New Zealand private radiation therapy joint venture between Allevia Hospitals and Southern Cross Healthcare. It operates two Auckland centres delivering CyberKnife, VMAT, IGRT, and other radiotherapy to referred cancer patients.

Ownership category

akta.pro rank

Product category

Radiation Oncology Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiation oncology
• Cancer treatment
• Stereotactic radiotherapy
• CyberKnife treatment
• Image-guided radiotherapy

Headquarters

HQ city

Epsom, Auckland

HQ country

New Zealand

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Radiation Therapy Treatment Services: Private radiation oncology treatment services for cancer patients. Services billed to patients directly or through health insurance providers. Treatment includes CyberKnife, VMAT, IGRT, SBRT and other radiation therapy techniques.
2. Private Healthcare Services: CyberKnife and advanced radiation therapy available as private healthcare options. Patients may be covered by health insurance or self-pay.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Auckland Radiation Oncology (ARO) is a private radiation oncology centre that delivers external-beam radiotherapy and stereotactic radiosurgery to cancer patients in Auckland, New Zealand. Its service portfolio includes CyberKnife robotic radiotherapy (the only site in New Zealand), conventional linear-accelerator treatments (VMAT, IGRT, IMRT, 3DCRT, electron), stereotactic body/intracranial radiotherapy (SBRT/SABR), and patient support services such as dietitian, physiotherapy and psychology care.

Product overview

Auckland Radiation Oncology operates as New Zealand's first and only private radiation oncology centre offering a comprehensive suite of radiation therapy services. The core technology portfolio includes the CyberKnife robotic radiotherapy system (the only one in New Zealand) for sub-millimeter precision cancer treatment, alongside Elekta linear accelerators and the advanced Elekta Evo system with AI-enhanced Iris imaging. Supporting infrastructure includes the Canon Aquilion Exceed Large Bore CT scanner (first in Australasia) for AI-powered treatment planning. ARO provides multiple treatment techniques including VMAT, IGRT, IMRT, SBRT/SABR, and 3DCRT. The centre operates two facilities (Epsom and North Shore) offering world-leading radiation therapy for prostate, brain, spine, liver, pancreatic, breast, lung, and other cancers, supported by comprehensive patient care services.

Differentiator

Problem solved

Functional benefit

Brands

• CyberKnife: Robotic radiotherapy system for precision cancer treatment, including prostate, brain, spine, liver, and pancreatic cancers.

Products and services

• CyberKnife Robotic Radiation Therapy Robotic stereotactic radiosurgery delivered via the Accuray CyberKnife S7 platform, offering sub-millimetre accuracy, real-time tumour tracking and AI-driven Iris collimation for patients seeking non-invasive treatment with fewer sessions (typically around five).
• Conventional and Advanced Linear Accelerator Radiation Therapy External-beam radiation therapy delivered on Elekta linear accelerators (including the Elekta Evo) using VMAT, IGRT, IMRT, 3D conformal, electron, SBRT/SABR and DIBH techniques, with RayStation planning and Vision RT surface guidance for personalised cancer treatment.
• Patient Support Services Multidisciplinary supportive care for patients undergoing radiation therapy, including dietitian consultations, physiotherapy, psychology/counselling, palliative care coordination, accommodation assistance and interpreter services for non-English-speaking patients.

Quantifiable outcome

• 96% cancer-free rate at 5 years for CyberKnife prostate cancer patients (PACE-B trial)
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature9 records

Partnerships

Six partnerships are on record, tiered minor and core.

• ASB BankminorGTM or Marketing Partner · 10 April 2026ASB Bank created a video 'Delivering World-Leading Cancer Care in NZ' featuring ARO's precision cancer care and CyberKnife technology. Demonstrates ASB's support for innovative healthcare in New Zealand.
• Cancer Society Auckland NorthlandcoreStrategic or Co-development Partner · 14 August 2024Renewed sponsorship partnership. ARO supports CSAN's accommodation service at Domain Lodge (home away from home for patients travelling to Auckland). Partnership provides wrap-around care for cancer patients and families/whanau affected by cancer.
• RaySearch (RayStation)coreTechnology or Integration · 1 September 2023Research agreement with world-leading oncology software provider. ARO was one of the first centres in the world to use RayStation with CyberKnife. Collaborating on next generation online adaptive radiotherapy development. ARO shares experience with other centres globally (New York, Australia, Asia).
• Allevia Hospitals (formerly MercyAscot)coreStrategic or Co-development Partner · 1 January 2008Joint venture partner owning and operating ARO. MercyAscot hospitals provide the site at Epsom. Allevia Properties Ltd owns the land and buildings at the Epsom site. Part of $40 million investment in advanced cancer care technology including CyberKnife.
• Southern Cross HealthcarecoreStrategic or Co-development Partner · 1 January 2008Joint venture partner in ARO. Part of $40 million investment partnership for radiation oncology technology and facilities. Supports funding for equipment purchases and business operations.
• Royal Marsden Hospital (UK)minorStrategic or Co-development PartnerChief Physicist Ian Hanson previously worked at Royal Marsden Hospital, one of UK's leading cancer hospitals. ARO's approach draws on world-leading UK cancer treatment practices.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Others

• RaySearch Laboratories: Swedish developer of the RayStation treatment planning software used by ARO for CyberKnife planning and a research partner on next-generation online adaptive radiotherapy. Directly relevant as ARO's software platform partner.
• Elekta: Swedish manufacturer of linear accelerators including the Elekta Evo with Iris imaging deployed at ARO's North Shore facility. Comparable as a critical equipment supplier whose technology roadmap shapes ARO's clinical capability.
• Accuray: Manufacturer of the CyberKnife robotic radiotherapy system installed at ARO and the only CyberKnife in New Zealand. Relevant as the technology vendor whose product is core to ARO's clinical differentiation.
• Southern Cross Healthcare (parent partner): JV partner in ARO and New Zealand's largest private surgical and healthcare network. Relevant as ARO's parent organisation and primary insurance-linked referral channel for radiation oncology services.
• Allevia Hospitals: JV partner in ARO (formerly MercyAscot Hospitals) and operator of the Epsom site where ARO's original facility is located. Relevant as ARO's parent and site host, with aligned surgical and specialist pathways feeding oncology referrals.

Broad incumbents

• Waikato Regional Cancer Centre: Public-sector radiation oncology service operated by Te Whatu Ora in Hamilton, serving the Midland region. Comparable as a radiation oncology provider in NZ, but publicly funded, larger in scale, and without ARO's premium private technology stack.
• Peter MacCallum Cancer Centre: Australia's only public specialist cancer hospital, operating advanced radiation therapy including SBRT and CyberKnife. Comparable as a specialty oncology provider in Australasia with broader scope (research, medical oncology, surgery) than ARO.

Direct peers

• Icon Cancer Centre: Australia's largest private cancer care operator with sites across Australia and New Zealand offering radiation therapy including VMAT, IGRT and SBRT. Closest direct competitor to ARO in the trans-Tasman private radiation oncology market and uses the same Elekta/Varian technology platforms.
• GenesisCare: Large private radiation oncology operator with clinics across Australia, New Zealand, the UK and Europe offering VMAT, IGRT, SBRT and stereotactic radiosurgery. Directly comparable to ARO on private-pay radiation oncology services and Elekta platform deployment.
• St George's Cancer Care Centre: Private cancer treatment centre in Christchurch providing radiation therapy and chemotherapy to South Island patients. Comparable to ARO as another private-pay radiation oncology provider in New Zealand, although without CyberKnife capability.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/auckland-radiation

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Auckland Radiation Oncology